Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Long-Term Investments: 2024

Historic Long-Term Investments for Stoke Therapeutics (STOK) over the last 1 years, with Dec 2024 value amounting to $29.8 million.

  • Stoke Therapeutics' Long-Term Investments rose 168.15% to $80.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.3 million, marking a year-over-year increase of 168.15%. This contributed to the annual value of $29.8 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Stoke Therapeutics reported Long-Term Investments of $29.8 million as of FY2024.
  • In the past 5 years, Stoke Therapeutics' Long-Term Investments registered a high of $29.8 million during FY2024, and its lowest value of $29.8 million during FY2024.
  • For the 1-year period, Stoke Therapeutics' Long-Term Investments averaged around $29.8 million, with its median value being $29.8 million (2024).